|
Tumor type |
D-Type |
|
A-Type |
|
T-Type |
|
D –Type |
|
Total
sample
492 |
n=230
44.3%
|
p<0.001
|
n=106
20.4% |
p<0.05 |
n=156
32.2%
|
p<0.02 |
n=230
44.3% |
| Size (mm) |
18.3 ± 13.2
|
p<0.05 |
21.7 ± 14.7 |
ns |
19.5 ± 10.8
|
ns |
18.3. ± 13.2 |
| DI |
1.04 ± 0.05 |
p<0.001 |
1.58 ± 0.15 |
p<0.001 |
1.98 ± 0.11 |
p<0.001 |
1.04 ± 0,05 |
|
SPF
% |
4,33 ± 6,47
|
p<0.001
|
15,7 ± 13,7 |
p<0.001 |
8,01 ± 9,00
|
p<0.001 |
4.33 ± 6,47 |
|
PI
% |
9.91 ± 8.48
|
p<0.001 |
23.7 ± 16.2 |
p<0.001 |
12.6 ± 11.8
|
p<0.01 |
9.91 ± 8,48 |
|
SSI rel.unit |
9,96 ± 6,64
|
p<0.001 |
20,7 ± 12,2 |
p<0.001
|
13,9 ± 9,87
|
p<0.001 |
9,96 ± 6,64 |
|
| Table 1: Presentation of the ploidy entities related to tumor size, DI, SPF, PI and SSI. The result of cytochemical parameters as DNA-index (DI), percentages of
S-phase (SPF), proliferation index (PI) and Stemline-Scatter-Index (SSI) analyzed at diagnosis and their relation to ploidy entities are shown. The difference between the
three ploidy entities D-, A-, and T-type tumors are statistically significant in all parameters except tumor size only between D- and A-type tumors. The D-type tumors are
placed both to the left and the right side in the Table to make all comparisons possible. |
